abstract |
FIELD: immunology.SUBSTANCE: application of cytolytic T-cell, cytolytic T-cell, CAR. Invention also discloses a nucleic acid molecule, an expression vector, a cell production method, a method of treating T-cell lymphoma or leukemia.EFFECT: present invention can find further application in therapy of oncological diseases associated with malignant T-cells.18 cl, 29 dwg, 6 tbl, 13 ex |